Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Survodutide

A Study in People With Obesity to Test the Effects of BI 456906 Compared With Semaglutide on Glucagon Receptor Activity in the Liver

Boehringer Ingelheim · Phase 1 · Active, not recruiting · Enrollment 29

NCT05202353

EudraCT 2021-000363-76

ArmPopulationDoseWeeksEstimandWeight change
Group 1: BI 456906Obesity or overweightn/r17n/rn/r
Group 2: SemaglutideObesity or overweightn/r17n/rn/r
Group 3: BI 456906Obesity or overweightn/r17n/rn/r
Group 4: SemaglutideObesity or overweightn/r17n/rn/r